Prevention of Rotavirus Gastroenteritis Among Infants and Children
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
August 11, 2006 / Vol. 55 / No. RR-12



In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq®) was licensed for use among U.S. infants. The Advisory Committee on Immunization Practices recommends routine vaccination of U.S. infants with 3 doses of this rotavirus vaccine administered orally at ages 2, 4, and 6 months. The first dose should be administered between ages 6–12 weeks. Subsequent doses should be administered at 4–10 week intervals, and all 3 doses should be administered by age 32 weeks. Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.

Comments: (0)